BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,988 | -38.3% | 5,538 | -25.5% | 0.00% | -33.3% |
| Q2 2023 | $338,634 | +49.4% | 7,433 | +33.0% | 0.01% | +50.0% |
| Q1 2023 | $226,683 | +1.0% | 5,589 | +27.0% | 0.00% | -20.0% |
| Q4 2022 | $224,336 | -33.6% | 4,401 | -29.8% | 0.01% | -28.6% |
| Q3 2022 | $338,000 | -15.3% | 6,272 | +1.0% | 0.01% | -12.5% |
| Q2 2022 | $399,000 | +99.5% | 6,207 | +166.3% | 0.01% | +166.7% |
| Q4 2021 | $200,000 | -4.3% | 2,331 | -5.8% | 0.00% | 0.0% |
| Q1 2021 | $209,000 | +1.0% | 2,474 | -3.9% | 0.00% | -25.0% |
| Q4 2020 | $207,000 | -24.7% | 2,574 | -24.8% | 0.00% | -20.0% |
| Q3 2020 | $275,000 | -6.5% | 3,423 | +0.2% | 0.01% | -16.7% |
| Q2 2020 | $294,000 | +0.3% | 3,417 | -5.5% | 0.01% | -25.0% |
| Q1 2020 | $293,000 | +1.0% | 3,615 | +4.2% | 0.01% | +33.3% |
| Q4 2019 | $290,000 | -7.6% | 3,470 | -3.4% | 0.01% | -14.3% |
| Q3 2019 | $314,000 | -78.2% | 3,591 | -79.6% | 0.01% | -78.8% |
| Q2 2019 | $1,439,000 | +4.7% | 17,571 | +4.0% | 0.03% | 0.0% |
| Q1 2019 | $1,374,000 | +37.0% | 16,903 | +10.9% | 0.03% | +17.9% |
| Q4 2018 | $1,003,000 | +272.9% | 15,243 | +336.9% | 0.03% | +300.0% |
| Q3 2018 | $269,000 | -9.4% | 3,489 | -13.3% | 0.01% | -22.2% |
| Q2 2018 | $297,000 | +29.1% | 4,026 | +14.0% | 0.01% | 0.0% |
| Q1 2018 | $230,000 | +7.0% | 3,531 | +6.0% | 0.01% | +12.5% |
| Q4 2017 | $215,000 | +2.4% | 3,331 | -0.4% | 0.01% | 0.0% |
| Q3 2017 | $210,000 | -20.2% | 3,345 | -23.0% | 0.01% | -11.1% |
| Q2 2017 | $263,000 | -80.4% | 4,345 | -84.5% | 0.01% | -84.7% |
| Q3 2016 | $1,339,000 | +3.5% | 28,121 | -1.7% | 0.06% | +1.7% |
| Q2 2016 | $1,294,000 | -16.7% | 28,612 | -24.3% | 0.06% | -23.7% |
| Q1 2016 | $1,553,000 | +7.0% | 37,815 | -0.6% | 0.08% | +4.1% |
| Q4 2015 | $1,452,000 | +6.8% | 38,062 | -8.0% | 0.07% | +2.8% |
| Q3 2015 | $1,359,000 | -67.8% | 41,378 | -31.6% | 0.07% | -63.0% |
| Q2 2015 | $4,227,000 | -25.6% | 60,450 | -27.1% | 0.19% | -25.9% |
| Q1 2015 | $5,682,000 | -4.2% | 82,942 | +2.5% | 0.26% | -7.8% |
| Q4 2014 | $5,932,000 | +55.8% | 80,937 | +52.6% | 0.28% | +49.5% |
| Q3 2014 | $3,807,000 | +68.5% | 53,043 | +69.8% | 0.19% | +64.9% |
| Q2 2014 | $2,259,000 | -0.4% | 31,245 | +1.4% | 0.11% | -8.1% |
| Q1 2014 | $2,267,000 | +31.2% | 30,813 | +24.0% | 0.12% | +44.2% |
| Q4 2013 | $1,728,000 | +27.2% | 24,851 | +20.1% | 0.09% | +17.8% |
| Q3 2013 | $1,359,000 | +62.2% | 20,691 | +71.1% | 0.07% | +55.3% |
| Q2 2013 | $838,000 | – | 12,091 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |